536745-81-0
Chemical Structure
C17 Globotriaosylceramide (d18:1/17:0)
Synonym(s): Ceramide trihexoside (d18:1/17:0); Gb3(d18:1)(C17:0)
- CAS No.: 536745-81-0
- Formula:C53H99NO18
- Molecular Weight:1038.35
InChIKey: FMSNZTFVKHTNKM-CNGLGKGFSA-N
SMILES: OC[C@@H](O[C@H]([C@@H]([C@H]1O)O)O[C@@H]2[C@H](O[C@H]([C@@H]([C@H]2O)O)OC[C@@H]([C@H](O)/C=C/CCCCCCCCCCCCC)NC(CCCCCCCCCCCCCCCC)=O)CO)[C@@H]1O[C@H]3O[C@@H]([C@@H]([C@@H]([C@H]3O)O)O)CO
Biological Activity: C17 Globotriaosylceramide (d18:1/17:0) is a sphygosine lipid that can be used to quantify Globotriaosylceramide in plasma and urine of patients with Fabry disease by gas chromatography-mass spectrometry (GC-MS)[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
C17 Globotriaosylceramide (d18:1/17:0) | 98.0% | C17 Globotriaosylceramide (d18:1/17:0) is a sphygosine lipid that can be used to quantify Globotriaosylceramide in plasma and urine of patients with Fabry disease by gas chromatography-mass spectrometry (GC-MS). | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||